|
31 |
Potency of botulinum toxin drugs: test systems and labelling Enthalten in Journal of neural transmission Bd. 129, 30.8.2022, Nr. 10, date:10.2022: 1309-1310
|
|
|
32 |
Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement Enthalten in Journal of neurology Bd. 262, 1.4.2015, Nr. 10, date:10.2015: 2201-2213
|
|
|
33 |
Quality of life and costs of spasticity treatment in German stroke patients Enthalten in Health economics review Bd. 6, 8.7.2016, Nr. 1, date:12.2015: 1-9
|
|
|
34 |
Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinA Enthalten in Health and quality of life outcomes Bd. 18, 4.3.2020, Nr. 1, date:12.2020: 1-10
|
|
|
35 |
The natural course of idiopathic cervical dystonia Enthalten in Journal of neural transmission Bd. 131, 20.1.2024, Nr. 3, date:3.2024: 245-252
|
|